Leptos Biomedical

About:

Leptos Biomedical offers a proprietary neuromodulation therapy solution for chronic obesity.

Website: http://www.leptosbiomedical.com/

Top Investors: Technology Partners, Thomas, McNerney & Partners, Latterell Venture Partners, Spray Venture Partners

Description:

Leptos Biomedical offers a proprietary neuromodulation therapy solution for chronic obesity. The company delivers its treatment, which involves the electrical activation of a nerve in the autonomic nervous system via a pacemaker-type device. Leptos Biomedical was founded in 2002 and is based in Fridley, Minnesota.

Total Funding Amount:

$26M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Mateo, California, United States

Founded Date:

2002-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2007-08-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai